NeuroPace (NPCE) EPS (Weighted Average and Diluted) (2020 - 2026)

NeuroPace's EPS (Weighted Average and Diluted) history runs 7 years deep, the most recent figure standing at -$0.2 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) rose 4.76% year-over-year to -$0.2; the TTM figure through Mar 2026 stood at -$0.65 (up 21.69% YoY), while the FY2025 annual figure was -$0.66, up 29.03% from the prior year.
• EPS (Weighted Average and Diluted) was -$0.2 for Q1 2026 at NeuroPace, down from -$0.08 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.08 in Q4 2025 to a low of -$0.52 in Q2 2022.
• Historically, EPS (Weighted Average and Diluted) has averaged -$0.29 across 5 years, with a median of -$0.26 in 2024.
• Biggest YoY gain for EPS (Weighted Average and Diluted) was 98.56% in 2022; the steepest drop was 41.18% in 2022.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.44 in 2022, then surged by 50.0% to -$0.22 in 2023, then climbed by 22.73% to -$0.17 in 2024, then surged by 52.94% to -$0.08 in 2025, then slumped by 150.0% to -$0.2 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.2 (Q1 2026), -$0.08 (Q4 2025), and -$0.11 (Q3 2025), per Business Quant data.